6Li Destri G, Rinzivillo C, Craxi G, et al. Colorectal follow-up planning modifiedon the basis of our personal experience. Dig Surg,1998,15(1)∶64-68.
7Mansel JK, Zinsmeister AR, Pairolero PC, et al. Pulmonary resection of metastaticcolorectal adenocarcinoma. A ten year experience. Chest,1986,89(1)∶109-112.
8Goya T, Miyazawa N, Kondo H, et al. Surgical resection of pulmonary metastases fromcolorectal cancer. 10-year follow-up. Cancer,1989,64(7)∶1418-1421.
1[3]Vigneswaran WT.Management of pulmonary metastases from colorectal cancer[J].semin Surg Onco1,1996,12(4):264.
2Moutain CF. Revisions in the international system forstaging lung cancer [J]. Chest, 1997,111 : 1710.
3Ferrare N, Henzel W. Pituitary foliar cell secrete a movel heprin-binding growth facror specific for vascular endothelial cells[J]. Bioc Bioph Res commun, 1989, 161-851.
4VIGNESWARAN W T.Management of pulmonary metastases from colorectal cancer[J].Semin Surg Oncol,1996,12(4):264-266.
5Mounain C F. Revisions in the international system for staging lung cancer[J]. Chest, 1997,111(6):1710-1717.
6Hiyoshi H, Matsuno Y, Kato H, et al. Clinicopathological significance of nuclear accumulation of tumor suppressor gene p53 product in primary lung cancer[J]. Jpn J Cancer Res, 1992,83 (1): 101-106.
7Kannan K, Amariglio N, Rechavi G, et al. DNA microarrays identification of primary and secondary target genes regulated by P53[J]. Oncogene, 2001,20 (18): 2225-2234.
8Wistuba U, Gazdar A F, Minna J D. Molocular genetics of small cell lung carcinoma[J]. Semin Oncol,2001,28 (2 Suppl4): 3-13.
9Niklinski J, Niklinska W, Chyczewski L, et al. Molecular genetic abnormalities in premalignant lung lesions: biological and clinical implications[J]. Eur J Cancer Prev, 2001,10(3): 213-226.
10Marchetti A, Buttitta F, Merlo G, et al. P53 alteration in non-small cell lung cancers correlate with metastatic involvement of hilar and mediastinal lymphnodes[J]. Cancer Res, 1993,53(12):2846-2851.
